BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18692682)

  • 1. Acute myeloid leukemia. Introduction.
    Bloomfield CD; Marcucci G; Döhner K; Döhner H
    Semin Oncol; 2008 Aug; 35(4):324-5. PubMed ID: 18692682
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Sill H
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy-related acute leukemia.
    Karp JE; Sarkodee-Adoo CB
    Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study.
    Björk J; Johansson B; Broberg K; Albin M
    Leuk Res; 2009 Jun; 33(6):788-91. PubMed ID: 19019430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are myelodysplastic syndromes and acute myeloid leukemia one disease?
    Gale RP; Bennett JM
    Leuk Res; 2009 Mar; 33(3):351-4. PubMed ID: 18996594
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.
    Sevcikova K; Zhuang Z; Garcia-Manero G; Alvarez RH; Kantarjian HM; Mego M; Albarracin C; Tang G; Strom SS; Medeiros LJ; Hortobagyi GN; Reuben JM; Khoury JD
    Leukemia; 2016 Jan; 30(1):242-7. PubMed ID: 25975189
    [No Abstract]   [Full Text] [Related]  

  • 7. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Sill H; Zinke-Cerwenka W; Berghold A
    Bone Marrow Transplant; 2007 Apr; 39(8):509; author reply 509-10. PubMed ID: 17322936
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy-related myelodysplastic syndromes and acute leukemias.
    Brusamolino E; Bernasconi C
    Leukemia; 1992 Nov; 6 Suppl 4():23-5. PubMed ID: 1434826
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of secondary acute myeloid leukemia.
    Pulsoni A; Pagano L
    J Clin Oncol; 2005 Feb; 23(4):926-7. PubMed ID: 15681547
    [No Abstract]   [Full Text] [Related]  

  • 10. MDS and acute monocytic leukaemia after retinoblastoma.
    Turner AR; Melynk A; Clark G
    Br J Haematol; 1996 Jan; 92(1):249. PubMed ID: 8562406
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms.
    Larson RA
    J Clin Oncol; 2012 Jul; 30(19):2300-2. PubMed ID: 22585693
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances and controversies in the biology and therapy of acute leukaemia and myelodysplasia.
    Rowe JM
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):475-8. PubMed ID: 19959095
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy-related myeloid neoplasms.
    Czader M; Orazi A
    Am J Clin Pathol; 2009 Sep; 132(3):410-25. PubMed ID: 19687318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
    Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
    Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study.
    Advani PG; Schonfeld SJ; Curtis RE; Dores GM; Linet MS; Sigel BS; Lam CJK; Tucker MA; Chanock SJ; Morton LM
    Leukemia; 2019 Dec; 33(12):2947-2978. PubMed ID: 31341236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Secondary leukemia].
    Nakamura H; Tomonaga M
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):177-9. PubMed ID: 9851114
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome.
    Callera F; Lopes CO; Rosa ES; Mulin CC
    Leuk Res; 2008 Oct; 32(10):1633-4. PubMed ID: 18405970
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    Leukemia; 2016 May; 30(5):1187-90. PubMed ID: 26369985
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemias.
    Krueger H; McLean D; Williams D
    Prog Exp Tumor Res; 2008; 40():45-50. PubMed ID: 18802387
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.
    Bousquet M; Quelen C; Rosati R; Mansat-De Mas V; La Starza R; Bastard C; Lippert E; Talmant P; Lafage-Pochitaloff M; Leroux D; Gervais C; Viguié F; Lai JL; Terre C; Beverlo B; Sambani C; Hagemeijer A; Marynen P; Delsol G; Dastugue N; Mecucci C; Brousset P
    J Exp Med; 2008 Oct; 205(11):2499-506. PubMed ID: 18936236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.